This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
They integrate with Slack, Microsoft Messenger, and other chat programs where they read the language you use, then turn on when you type in a trigger phrase. That’s why critics say these programs are always listening; if they weren’t, they’d never know when you need them. NLTK is offered under the Apache 2.0 Amazon Comprehend.
Icosavax creates virus-like particles with technology licensed from the University of Washington’s Institute for Protein Design. The company launched its COVID program in October, supported in part by $10 million from the Bill & Melinda Gates Foundation. Icosavax Photo).
Senior executives in some industries—technology, finance, and pharmaceuticals—are most comfortable making assertions and sharing facts, Keeley notes. I’m also licensed as one of about 60 storytellers worldwide to deliver workshops and training programs from Anecdote.com , which also shares a lot of great free resources.
Senior executives in some industries—technology, finance, and pharmaceuticals—are most comfortable making assertions and sharing facts, Keeley notes. I’m also licensed as one of about 60 storytellers worldwide to deliver workshops and training programs from Anecdote.com , which also shares a lot of great free resources.
The funding will fuel Alpine’s program developing ALPN-303, designed to treat lupus and other inflammatory diseases. That payment is part of a licensing deal inked last year with the pharmaceutical giant for clinical testing of another immune-modulating agent, ALPN-101, for lupus. million shares of common stock and 3.2
based biotechnology company struck a deal with Merck in which the pharmaceutical powerhouse will provide a $600 million upfront payment and make a $1 billion equity investment to continue development of treatments for breast cancer. (Seattle Genetics Photo). Merck will own about 2.9
The UW has licensed the exclusive rights of this intellectual property to the startup. This funding will allow us to build upon our promising preliminary data demonstrating detection of Alzheimer’s disease at its earliest stages and further our preclinical therapeutic program,” Daggett said in a statement.
It’s been a “big challenge to shift from a device technology-focused company to what is now a pretty integrated pharmaceutical company,” said Hoekman. The second program is for Parkinson’s disease. Both programs leverage existing drugs but deliver them through Impel’s POD system for rapid action.
Founded in 2018, Vouched helps companies verify the identity of customers and users by examining driver’s licenses and other forms of identification. The new arrangement created a single institution that combined research and patient care and also serves as University of Washington Medicine’s cancer program. Bothell, Wash.-based
They licensed the AbC technology from UW and incorporated Archon Biosciences in 2023. James and George have assembled a team of world-class scientists and pharmaceutical industry veterans that is able to create new preclinical molecules with extraordinary speed and accuracy,” Picardo said. ” .
The startup has an exclusive license to use novel CAR T-cell technology developed by Jensen and his team. “With our clinical trials and our academic programs, we can treat and help dozens or tens of dozens of patients,” Jensen said. Steven Brugger will join BrainChild Bio as CEO.
Varda has been working on a space-based manufacturing system that processes materials in orbit to produce pharmaceuticals, with the finished products shipped back down to Earth. ” The XPRIZE Foundation specializes in this kind of prize program, but the Mars Society has done prizes as well, albeit on a smaller scale.
Commercial customers pay a licensing fee, while academics access the Rosetta code for free — and build and improve on it. Antibodies are really the key molecules for protein therapeutics in the pharmaceutical industry. The IPD has a translational investigator program where you stay on for a year or two after you finish your Ph.D.,
So you buy a processing unit design from somebody like Arm in the UK, who is very popular, and then maybe you need the USB interface, so you get a USB IP block, which you license. So you decide, “I want to build a controller chip.” Moderna, for example, had been working on it for a decade with $1 billion of private capital invested.
But a federal prosecutor in the Northern District of California sent PCRM’s complaint to the USDA Inspector General (OIG), a federal office charged with investigating and auditing USDA programs, which then opened a formal probe, according to Reuters. It’s what Winders calls “animal experimentation exceptionalism.”.
Gloves embedded with these kinds of sensors also can be programmed to give the impression of touching hard or soft surfaces, such as bedposts, whip handles or buttocks. Add a dose of pharmaceuticals - legal or illegal - and things could get very interesting. Visionary Marshall McLuhan said the media are extensions of our senses.
to come out firmly for the TRIPS [intellectual property] waivers so that we could license these vaccines around the globe, wherever there was capacity, and make sure that we could produce them in other countries. . “The U.S. and all of the other wealthier countries have to put a lot more money in.” That is really critical.
Principles, rather than programming. Andrew Caballero-Reynolds/AFP via Getty Images Gary Marcus, left, and Sam Altman are among the prominent AI voices calling for a licensing regime. This would effectively require certain algorithms to receive a government “license” before they can be publicly released.
Prior to 230, like when we were doing Broadcast.com and AudioNet, any piece of content that I have put on there, I had to have a license for it. They have to get a license before they put that on CNN, right? Not more programs, but stimulus. Because prior to 230 —. I disagree. So let me finish that. End of story. But we’re going.
We organize all of the trending information in your field so you don't have to. Join 83,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content